Catalysts for Navinta LLC
4 tracked
Feb 17, 2026
approval
SODIUM PHENYLBUTYRATE — FDA approval
SODIUM PHENYLBUTYRATE
→
Feb 15, 2026
grant
WASHINGTON UNIVERSITY — Novel Use of Fomepizole in Hepatic Ischemia Reperfusion Injury
Navinta LLC
→
Nov 14, 2025
approval
DIAZEPAM — FDA approval
DIAZEPAM
→
Oct 27, 2025
approval
SEVELAMER CARBONATE — FDA approval
Renvela
→